Effect of oral ketamine on secondary hyperalgesia, thermal and mechanical pain thresholds, and sedation in humans

Regional Anesthesia and Pain Medicine

Volumn 25, Issue 5, 2000, Pages 452-458

  Mikkelsen, Soren ^a   Jorgensen, Henrik ^a   Larsen, Pia S ^a   Brennum, Jannick ^b   Dahl, Jorgen B ^a  

^a Mental Health Center Glostrup   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Hyperalgesia; Oral ketamine

Indexed keywords

KETAMINE; PLACEBO;

ADULT; ARTICLE; BURN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; HALLUCINATION; HEAT INJURY; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; MALE; NAUSEA; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SENSITIZATION; SPINAL CORD DORSAL HORN; THERMAL STIMULATION; TISSUE INJURY; VOLUNTEER;

EID: 0033799669     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1053/rapm.2000.8456     Document Type: Article

References (38)

1. The spinal pharmacology of facilitation of afferent processing evoked by high-threshold afferent input of the postinjury pain state
2. Spinal cord pharmacology of pain
3. Central mechanisms of acute pain
4. Somatic pain - Pathogenesis and prevention
5. Peripheral and central mechanisms of cutaneous hyperalgesia
6. Neurogenic hyperalgesia: The search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia
7. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans
8. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
9. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
10. Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons
11. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans
12. Evidence for involvement of N-methyl-D-aspartate receptors in wind-up of class 2 neurones in the dorsal horn of the rat
13. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation
14. Ketamine acts as a non competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro
15. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: A double-blind, cross-over comparison with morphine and placebo
16. The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans
17. Ketamine as an induction agent in anaesthetics
18. Pharmacokinetics and analgesic effects of i.m. and oral ketamine
19. The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input
20. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery
21. Ketamine in the management of intractable phantom pain
22. Oral ketamine therapy in the treatment of postamputation stump pain
23. Ketamine injection used orally
24. Analgesic effect of ketamine in a patient with neuropathic pain
25. Norketamine, the metabolite of ketamine, is a noncompetitive NMDA receptor antagonist in the rat cortex and spinal cord
26. Quantitative sensory examination of epidural anaesthesia and analgesia in man. Effects of pre- and posttraumatic morphine on hyperalgesia
27. The effect of pre- versus postinjury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin
28. Time course of primary and secondary hyperalgesia after heat injury to the skin
29. Hyperalgesia in a human model of acute inflammatory pain: A methodological study
30. Pressure pain thresholds in volunteers and herniorrhaphy patients
31. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans
32. Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade
33. Four years' treatment with ketamine and a trial of dextrometorphan in a patient with severe post-herpetic neuralgia
34. Successful treatment of postherpetic neuralgia with oral ketamine
35. Oral ketamine and transdermal nitroglycerine as analgesic adjuvants to oral morphine therapy for cancer pain management
36. Clinical experience with oral ketamine
37. Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain
38. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: A placebo-controlled experimental human study